一个ROS/光双响应前药物单分子细胞,用于增强癌症免疫疗法
Zeqian Huang1, Congjun Xu1,2, Yaqing Ding1
1School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China.
Asian journal of pharmaceutical sciences
|March 11, 2026
概括
一种新型的双响应前药菌 (PPTN) 结合了光动力疗法 (PDT) 与胺-2,3-二氧化酶 (IDO) 抑制. 这种方法通过触发免疫细胞死亡并增强对瘤的免疫反应来增强癌症免疫疗法.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术纳米技术
- 癌症研究 癌症研究
背景情况:
- 光动力学疗法 (PDT) 与免疫抑制逆转相结合显示出癌症免疫疗法的前景.
- 目前的纳米药物输送系统面临临临床翻译的挑战,因为复杂性和准备困难.
研究的目的:
- 开发一种新的,无载体的前药物输送系统,用于增强癌症免疫治疗.
- 创建一个双响应系统,将PDT与IDO抑制相结合,以获得协同治疗效果.
主要方法:
- 合成了一种反应性氧物种 (ROS) /光双响应性两性病原原药 (PPTN) 通过将一种 IDO 抑制剂 (NLG919) 与一种光敏化剂 (protoporphyrin IX) 通过一种 thioketal 链接剂连接起来,该链接剂经过mPEG2k.
- PPTN自组装成纳米级单分子,增强瘤积累和解决疏水性.
- 研究了PPTN对暴露于光线的反应,导致ROS生成和同时释放NLG919.9.
主要成果:
- PPTN自组装成稳定的单分子,改善瘤向性和药物溶解性.
- 暴露于光线触发了ROS的产生,直接损害瘤细胞,并释放了NLG919,抑制了IDO.
- 该系统诱导了PDT触发的免疫细胞死亡 (ICD) 和IDO阻断,显著抑制了初级和远程瘤.
结论:
- 开发的ROS/光双响应前药细胞 (PPTN) 提供了一个简化,无载体的可控药物递送平台.
- 通过联合PDT和IDO抑制,PPTN显示出强大的抗瘤疗效,突出显示了其在光激活免疫治疗中的潜力.
相关概念视频
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.


